IDSA/ESCMID:女性急性单纯性膀胱炎和肾盂肾炎的临床治疗指南

2011-03-01 美国感染病学会 Clin Infect Dis. 2011,52(5):e103-e120

ESC

中文标题:

IDSA/ESCMID:女性急性单纯性膀胱炎和肾盂肾炎的临床治疗指南

英文标题:

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious D

发布机构:

美国感染病学会

发布日期:

2011-03-01

简要介绍:

美国感染性疾病学会(IDSA)和欧洲临床微生物与感染性疾病学会(ESCMID)发布了女性急性单纯性膀胱炎和肾盂肾炎的临床治疗指南。论文即将于3月发表于《临床感染性疾病》[Clin Infect Dis 2011,52 (5): 561]杂志。该指南的主要内容为:① 女性急性单纯性膀胱炎的治疗,包括甲硫氧嘧啶、β-内酰胺类、氟喹诺酮类等抗生素的使用指导;② 女性急性肾盂肾炎的治疗,包括诊断注意事项、抗生素的使用指导及住院患者治疗的注意事项等。须注意,该指南仅适用于无已知尿路畸形或尿路合并症的绝经期前及未妊娠的女性。

评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1057530, encodeId=1bfe105e530ee, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:17:45 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804709, encodeId=fe5e804e0904, content=受益匪浅 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:23:32 CST 2020, time=2020-07-27, status=1, ipAttribution=)]
    2021-10-04 H8888888

    不错 谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1057530, encodeId=1bfe105e530ee, content=不错 谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Mon Oct 04 14:17:45 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=804709, encodeId=fe5e804e0904, content=受益匪浅 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200727/b60a77553cbf4c52960f34b84b45a8ed/58e49ab1cc054e63aed4f295473d6cab.jpg, createdBy=84245401923, createdName=你好, createdTime=Mon Jul 27 10:23:32 CST 2020, time=2020-07-27, status=1, ipAttribution=)]
    2020-07-27 你好

    受益匪浅

    0